eMedicine Specialties > Endocrinology > Thyroid

Iodine Deficiency: Treatment & Medication

Author: Stephanie L Lee, MD, PhD, Fellow, Association of Clinical Endocrinology; Director of Thyroid Nodule and Cancer Center, Associate Chief, Section of Endocrinology, Diabetes and Nutrition, Boston Medical Center; Associate Professor, Department of Medicine, Boston University School of Medicine
Coauthor(s): Sonia Ananthakrishnan, MD, Attending Physician, Department of Medicine, Section of Endocrinology, Diabetes and Nutrition, Boston University School of Medicine/Boston Medical Center; Elizabeth N Pearce, MD, MSc, Assistant Professor of Medicine, Boston Medical Center/Boston University Medical School
Contributor Information and Disclosures

Updated: Apr 22, 2009

Treatment

Medical Care

Long-term dietary iodine replacement at levels recommended by the IOM and WHO may decrease the size of iodine-deficient goiters in very young children and pregnant women and is indicated for all patients with iodine deficiency.4 Generally, long-standing goiters associated with iodine deficiency disorder respond with only small amounts of shrinkage after iodine supplementation, and patients are at risk for developing hyperthyroidism. Patients do not routinely require specific therapy unless the goiter is large enough to cause compressive symptoms (eg, tracheal obstruction, thoracic inlet occlusion, hoarseness).

  • Correction of an iodine deficiency
    • This should be instituted based on the recommendations of the IOM and the WHO.
    • In an adult, 150 mcg/d is sufficient for normal thyroid function. Using highly concentrated pharmaceutical agents, such as a saturated solution of potassium iodide (SSKI), ie, 35,000-50,000 mcg/drop, is impractical and potentially dangerous.
    • Not all daily or prenatal multiple vitamins contain iodine. Adult multiple vitamins that contain iodine typically contain 150 mcg of iodine per tablet.
    • Replacement of iodine is most easily achieved by requesting that the patient use iodized salt in their cooking and at the table. Other alternative food sources include milk, egg yolks, and saltwater fish.
    • In developing countries, eradication of iodine deficiency has been accomplished by adding iodine drops to well water or by injecting people with iodized oil.
  • Treatment of nontoxic goiters caused by iodine deficiency
    • Exogenous L-thyroxine (L-T4) can also be used to decrease goiter size but generally is not effective in adults and older children. Supplemental L-T4, when added to the T3 and T4 secretion by the autonomous nodules in the endemic goiter, may cause thyrotoxicosis. Long-term L-T4 therapy that results in the suppression of the TSH level to below-normal levels may have deleterious effects on cardiac and bone health; therefore, L-T4 therapy is no longer routinely administered to patients with goiter. (See the eMedicine topics Thyroiditis, Subacute and Hyperthyroidism for more information.)
    • Radioactive iodine (iodine-131 [131 I]) has been used, primarily in Europe, to decrease thyroid volume in patients with euthyroid goiters (40-60% volume reduction). In the United States,131 I is the most common treatment for toxic multinodular goiters associated with hyperthyroidism.

Surgical Care

Thyroidectomy may be indicated for patients with compressive symptoms of a large goiter.

Consultations

Consultation with an endocrinologist should be considered when the etiology of thyroid abnormalities is unclear.

Diet

The WHO recommendations for iodine intake are 150 mcg/d for adults and adolescents, 200 mcg/d for pregnant or lactating women, 90-120 mcg/d for children aged 1-11 years, and 50-90 mcg/d for infants younger than 1 year. The IOM recommends 150 mcg/d for adults, 220 mcg/d for pregnant women, and 290 mcg/d for lactating women.3,4,5,6

  • Data collected in the United States for NHANES I for the years 1971-1974 showed that the median urine iodine was 320 mcg/L, reflecting adequate dietary iodine intake.7  However, by the time of NHANES III (1988-1994), the median urinary iodine had fallen to 145 mcg/L. The NHANES 2001-2002 demonstrates the current stability of iodine intake in the United States at 167.8 mcg/L.8
  • Between previous NHANES surveys, the risk for insufficient dietary iodine intake in reproductive-aged women (15-44 y) increased 3.8-fold. This overall decrease in dietary iodine may be a result of reduced intake of eggs and salt, decreased iodine supplementation of cattle feed, decreased iodate conditioners in bread, decreased use of iodized salt in manufactured foods, poor education about the medical necessity of using iodized salt, and reduction in the number of meals made at home.8,9,7

Activity

No restrictions are needed.

Medication

Correction of an individual's iodine deficiency should be instituted at a level recommended by the Food and Drug Administration (FDA) and the WHO. In an adult, 150 mcg/d is sufficient for normal thyroid function. Using highly concentrated pharmaceutical agents, such as SSKI (35,000-50,000 mcg/gtt), is impractical and potentially dangerous. Replacement of iodine is achieved most easily by requesting that the patient use iodized salt (70 mcg/g) in their cooking and at the table. Other alternative food sources include milk, egg yolks, and saltwater fish. In developing countries, eradication of iodine deficiency has been accomplished by adding iodine drops to well water or by injecting people with iodized oil.

Adult multiple vitamins do not all contain iodine. Those that do, typically contain iodine have 150 mcg per tablet.

131 I has been used in Europe to decrease the size of nontoxic goiters caused by iodine deficiency. This is not the standard of care in the United States. Risks associated with131 I therapy include permanent hypothyroidism.

Iodides

Iodine deficiency has been treated at a population level by several methods, including voluntary use of iodized salt, iodine supplementation in bread and water, and PO/IM administration of iodized oil. The simplest and least expensive treatment is to have the patient purchase and use iodized salt.


Potassium iodide (Lugol solution, SSKI, Pima)

Option in industrialized counties. Absorption from GI tract is rapid and complete. Skin and lungs also can absorb iodine. Iodine equilibrates in extracellular fluids and is specifically concentrated by thyroid gland.

Adult

150 mcg/d PO
200 mcg/d PO for pregnant and lactating women
Potassium iodide: 24,000 mcg/mL
Lugol solution: 6300 mcg/gtt
SSKI: 35,000 mcg/gtt

Pediatric

Infants: 50-90 mcg/d PO
1-11 years: 90-120 mcg/d PO

Very high intake of iodine (>1000 mcg/d) increases lithium toxicity by producing additive hypothyroid effects

Documented hypersensitivity to large doses (>1000 mcg/d); pulmonary edema, bronchitis, tuberculosis, and hyperkalemia
Patient with an iodine deficiency goiter may become thyrotoxic after supplementation with iodine; patients with toxic multinodular goiter should not be treated with excess iodine because this may worsen hyperthyroidism

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

Precautions

Iodine alone is not effective in shrinking adult nodule goiters due to iodine deficiency, iodine will shrink diffuse goiters in children with iodine deficiency; Prolonged intake of high levels of iodine (>1000 mcg/d) may result in fetal and maternal hypothyroidism and goiter; caution in renal failure and GI obstruction; iododerma, coryza, cough, nausea, rhinorrhea, and parotitis may occur; prolonged use at high levels during pregnancy may cause obstructive fetal goiter

Thyroid hormones

Thyroid hormone, L-thyroxine, may be used to treat iodine deficiency, because the chemical content of iodine is approximately 60% by weight.


Levothyroxine (Synthroid, Levothroid, Levoxyl)

Generally effective in replacing iodine deficiency. Considerably more expensive preparation than other forms of iodine (eg, iodized salt), especially when combined with the added expense of measuring TSH levels to assure that the supplemental L-thyroxine has not resulted in iatrogenic hyperthyroidism. Alternatively, thyroid hormone therapy has been used with caution to shrink the goiter of iodine deficiency. An L-thyroxine dose is chosen that maintains the TSH in the lower part of the reference range. TSH levels should be monitored carefully to avoid thyrotoxicosis due to autonomous nodules in the iodine deficiency goiter.

Adult

12.5-50 mcg/d and increase by 25-50 mcg/d q2-4wk, not to exceed 100-200 mcg/d; adjust dose q8wk based on measured TSH level to maintain TSH in lower part of reference range; once TSH level has stabilized, TSH level should be measured and L-thyroxine dose adjusted every 6 mo to make sure TSH remains at desired target range

Pediatric

6-12 months: 50-75 mcg/d
1-5 years: 75-100 mcg/d
6-12 years: 100-150 mcg/d
>12 years: 150 mcg/d
Adjust dose q4-6wk to maintain TSH in lower part of reference range

Cholestyramine may decrease L-T4 absorption; concomitant administration with calcium or iron supplements may decrease absorption; estrogens may increase daily thyroid hormone requirement in patients with nonfunctioning thyroid glands; effect of anticoagulants increased when administered with liothyronine; activity of some beta-blockers may decrease when hypothyroid patient is converted to a euthyroid state

Documented hypersensitivity; uncorrected adrenal insufficiency

Pregnancy

A - Fetal risk not revealed in controlled studies in humans

Precautions

Caution in angina pectoris or cardiovascular disease; monitor thyroid status periodically

More on Iodine Deficiency

Overview: Iodine Deficiency
Differential Diagnoses & Workup: Iodine Deficiency
Treatment & Medication: Iodine Deficiency
Follow-up: Iodine Deficiency
Multimedia: Iodine Deficiency
References
Further Reading

References

  1. Zimmermann MB, Jooste PL, Pandav CS. Iodine-deficiency disorders. Lancet. Oct 4 2008;372(9645):1251-62. [Medline].

  2. de Benoist B, McLean E, Andersson M, Rogers L. Iodine deficiency in 2007: global progress since 2003. Food Nutr Bull. Sep 2008;29(3):195-202. [Medline].

  3. Zimmermann MB. Iodine deficiency in pregnancy and the effects of maternal iodine supplementation on the offspring: a review. Am J Clin Nutr. Feb 2009;89(2):668S-72S. [Medline].

  4. WHO Secretariat, Andersson M, de Benoist B, Delange F, Zupan J. Prevention and control of iodine deficiency in pregnant and lactating women and in children less than 2-years-old: conclusions and recommendations of the Technical Consultation. Public Health Nutr. Dec 2007;10(12A):1606-11. [Medline].

  5. Delange F. Optimal iodine nutrition during pregnancy, lactation and neonatal period. Int J Endocrinol Metab. 2004;89:3851.

  6. Azizi F, Smyth P. Breastfeeding and maternal and infant iodine nutrition. Clin Endocrinol (Oxf). May 2009;70(5):803-9. [Medline].

  7. Hollowell JG, Staehling NW, Hannon WH, et al. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994). J Clin Endocrinol Metab. Oct 1998;83(10):3401-8. [Medline][Full Text].

  8. Caldwell KL, Jones R, Hollowell JG. Urinary iodine concentration: United States National Health And Nutrition Examination Survey 2001-2002. Thyroid. Jul 2005;15(7):692-9. [Medline].

  9. Caldwell KL, Miller GA, Wang RY, Jain RB, Jones RL. Iodine status of the U.S. population, National Health and Nutrition Examination Survey 2003-2004. Thyroid. Nov 2008;18(11):1207-14. [Medline].

  10. Williams GR. Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol. Jun 2008;20(6):784-94. [Medline].

  11. Zimmermann MB, Moretti D, Chaouki N, et al. Development of a dried whole-blood spot thyroglobulin assay and its evaluation as an indicator of thyroid status in goitrous children receiving iodized salt. Am J Clin Nutr. Jun 2003;77(6):1453-8. [Medline][Full Text].

  12. Zimmermann MB. Iodine requirements and the risks and benefits of correcting iodine deficiency in populations. J Trace Elem Med Biol. 2008;22(2):81-92. [Medline].

  13. Cerqueira C, Knudsen N, Ovesen L, et al. Association of iodine fortification with incident use of anti-thyroid medication - A Danish nationwide study. J Clin Endocrinol Metab. Apr 14 2009;[Medline].

  14. DeLange FM. Iodine deficiency. In: Braverman L, Utiger RD, eds. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2000:295-316.

  15. Dunn JT. IDD Newsletter. International Council for Control of Iodine Deficiency Disorders. 2001.

  16. Dunn JT, Van der Har F. A practical guide to the correction of iodine deficiency. The Netherlands: International Council for Control of Iodine Deficiency Disorders. 1990.

  17. Hetzel BS. The Story of Iodine Deficiency: An International Challenge in Nutrition. New York, NY: Oxford University Press; 1989.

  18. Hetzel BS, DeLange F. The iodine deficiency disorders. Thyroid Disease Manager [serial online]. 2001. Available from: Worchester, Mass: Endocrine Education. Available at http://www.thyroidmanager.org/Chapter20/20-frame.htm.

  19. Lee K, Bradley R, Dwyer J, Lee SL. Too much versus too little: the implications of current iodine intake in the United States. Nutr Rev. Jun 1999;57(6):177-81. [Medline].

  20. Santiago-Fernandez P, Torres-Barahona R, Muela-Martínez JA, et al. Intelligence quotient and iodine intake: a cross-sectional study in children. J Clin Endocrinol Metab. Aug 2004;89(8):3851-7. [Medline][Full Text].

  21. Zimmermann MB, Aeberli I, Torresani T, et al. Increasing the iodine concentration in the Swiss iodized salt program markedly improved iodine status in pregnant women and children: a 5-y prospective national study. Am J Clin Nutr. Aug 2005;82(2):388-92. [Medline][Full Text].

  22. Zimmermann MB, Wegmuller R, Zeder C, et al. Rapid relapse of thyroid dysfunction and goiter in school-age children after discontinuation of salt iodization. Am J Clin Nutr. Apr 2004;79(4):642-5. [Medline][Full Text].

Keywords

iodine deficiency, thyroid, iodine, hypothyroidism, thyroid disease, hyperthyroidism, hypothyroid, thyroid symptoms, thyroiditis, hyperthyroid, thyroid hormone, goiter symptoms of thyroid, iodine supplements, symptoms of thyroid problems, thyroid disorder, thyroxinethyroid disorders, thyroid tests, thyroid hormones, T3 thyroid, T4 thyroid, thyrotoxicosis, iodine foods, iodine diet, iodine supplement, iodine deficiency disorders, endemic goiter, cretinism, mental retardation

Contributor Information and Disclosures

Author

Stephanie L Lee, MD, PhD, Fellow, Association of Clinical Endocrinology; Director of Thyroid Nodule and Cancer Center, Associate Chief, Section of Endocrinology, Diabetes and Nutrition, Boston Medical Center; Associate Professor, Department of Medicine, Boston University School of Medicine
Stephanie L Lee, MD, PhD is a member of the following medical societies: American College of Endocrinology, American Thyroid Association, and Endocrine Society
Disclosure: Nothing to disclose.

Coauthor(s)

Sonia Ananthakrishnan, MD, Attending Physician, Department of Medicine, Section of Endocrinology, Diabetes and Nutrition, Boston University School of Medicine/Boston Medical Center
Disclosure: Nothing to disclose.

Elizabeth N Pearce, MD, MSc, Assistant Professor of Medicine, Boston Medical Center/Boston University Medical School
Elizabeth N Pearce, MD, MSc is a member of the following medical societies: American Association of Clinical Endocrinologists, American Thyroid Association, Endocrine Society, and Massachusetts Medical Society
Disclosure: Abbott Laboratories Consulting fee Consulting

Medical Editor

Harris C Taylor, MD, Clinical Professor of Medicine, Division of Clinical and Molecular Endocrinology, Case Western Reserve University School of Medicine
Harris C Taylor, MD is a member of the following medical societies: American Association of Clinical Endocrinologists, American College of Physicians, American Thyroid Association, and Endocrine Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Arthur B Chausmer, MD, PhD, FACP, FACE, FACN, CNS, Professor of Medicine (Endocrinology, Adj), Johns Hopkins School of Medicine; Affiliate Research Professor, Bioinformatics and Computational Biology Program, School of Computational Sciences, George Mason University; Principal, C/A Informatics, LLC
Arthur B Chausmer, MD, PhD, FACP, FACE, FACN, CNS is a member of the following medical societies: American Association of Clinical Endocrinologists, American College of Endocrinology, American College of Nutrition, American College of Physician Executives, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Medical Informatics Association, American Society for Bone and Mineral Research, American Society of Law Medicine and Ethics, Endocrine Society, and International Society for Clinical Densitometry
Disclosure: Nothing to disclose.

CME Editor

Mark Cooper, MBBS, PhD, FRACP, Head, Diabetes & Metabolism Division, Baker Heart Research Institute, Professor of Medicine, Monash University
Disclosure: Nothing to disclose.

Chief Editor

George T Griffing, MD, Professor of Medicine, St Louis University School of Medicine
George T Griffing, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Medical Practice Executives, American College of Physician Executives, American College of Physicians, American Diabetes Association, American Federation for Medical Research, American Heart Association, Central Society for Clinical Research, Endocrine Society, International Society for Clinical Densitometry, and Southern Society for Clinical Investigation
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.